Caricamento...
Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancer
With the advent of new drugs and therapeutic combinations for metastatic colorectal cancer, the prognosis for this often incurable disease is improving. In addition to traditional cytotoxic chemotherapeutics, targeted biologic therapies, such as cetuximab, panitumumab, bevacizumab, aflibercept and r...
Salvato in:
| Pubblicato in: | Hepat Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Future Medicine Ltd
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095158/ https://ncbi.nlm.nih.gov/pubmed/30190967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.14.13 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|